Skip to main content
. 2021 Sep 11;13(9):1452. doi: 10.3390/pharmaceutics13091452
OH hydroxyl radicals
andro andrographolide
AIE aggregation-induced emission
ASOs antisense oligonucleotides
BSA bovine serum albumin
CeO2 cerium oxide
CVDs cardiovascular diseases
H2O2 hydrogen peroxide
HA hyaluronic acid
HASF oligomeric hyaluronic acid-2′-[propane-2,2-diyllbls(thio)] diacetic acl-hydroxymethylferrocene
LDL low-density lipoprotein
Lp liposomes
MacTNP macrophage-targeted theranostic nanoparticles
MMP matrix metalloproteinase
MnO2 manganese dioxide
mTOR mammalian target of rapamycin
NIRF near-infrared fluorescence
O2- superoxide
ONOO peroxide nitrate
Ox-LDL low-density lipoprotein
PBAPs phenylboronic acid pinacol esters
PEG polyethylene glycol
PEG–PPS poly(ethylene glycol)–poly(propylene sulfide)
PGED–PPS poly(glycidyl methacrylate)–polypropylene sulfide
PPS polypropylene sulfides
RNAi RNA interference
ROS reactive oxygen species
S2P stabilin-2-specific peptide ligand
siRNA short interfering RNA
TEMPOL 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl
TP two-photon fluorophore
TPCD superoxide dismutase mimetic agent TEMPO and PBAP in β-cyclodextrin
VSMCs vascular smooth muscle cells